Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Reanalysis of the Rituximab in ANCA-Associated Vasculitis trial identifies granulocyte subsets as a novel early marker of successful treatment

Fig. 1

Overview of the analytical process, starting with open access clinical trial data. Solid black arrows represent work carried out by the primary investigators. White arrows represent work done in the present study, enabled by the public accessibility of the original raw trial data. Dashed black arrows represent future work that could be triggered by the reanalysis process

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us